FeesSafety
Pluang+

Merit Medical posts 9% organic revenue growth in Q3 2026 and raises full-year guidance

Company Fundamentals
29 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Bullish
Merit Medical posts 9% organic revenue growth in Q3 2026 and raises full-year guidance

Merit Medical Systems reported an 8.4% revenue increase to $416.2 million in Q3 2026, driven by 9% organic growth excluding acquisitions and divestitures. The company improved GAAP operating margin to 14.1% and non-GAAP EPS rose 22% to $1.12. Strong demand across U.S. markets and key product platforms supported results, prompting Merit to raise its 2026 revenue and earnings guidance. Management remains confident in achieving continued growth and profitability targets through strategic initiatives and acquisitions.

Merit Medical's Q3 2026 results provide context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 30, 2026 03:11 WIB: Among 150 priced US health stocks, 106 rose and 44 fell today. Mesoblast (MESO) surged 16.73% to USD 15.63 with a typical hold time of 15 days and 80% sell order activity, contrasting with Illumina (ILMN), which dropped 14.82% to USD 246.00 with a much longer hold time of 84 days and 100% sell orders. Haleon (HLN) fell 14.20% to USD 8.58 but saw 100% buy order activity and a short 7-day hold time.

More News

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb adds eBay's Jordan Sweetnam to board to boost global eCommerce growth and customer experience.

iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...

Company Fundamentals
Bullish
3 hours ago
Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals shares drop over 28% after lowering 2026 sales guidance, prompting fraud investigation.

Alnylam Pharmaceuticals announced on July 30, 2026, that it lowered its full-year 2026 sales guidance for its TTR product by about $200 million due to slower than expected market growth. This caused the stock to fall 28.31%, injuring investors. On Oc...

Market News
Bearish
4 hours ago
Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token rises 3% in an hour, gains 17.28% in 24 hours amid heavy liquidations.

Hyperliquid (HYPE) token price increased by 3.00% within one hour on October 29, reaching $94.82 on Binance. Over the same 24-hour period, HYPE gained 17.28%, reflecting strong upward momentum. During this hour, significant liquidations occurred with...

Market News
Bullish
4 hours ago
Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson seen overvalued at 27x P/E with weak earnings and limited growth outlook through 2027.

Harley-Davidson is currently trading at a high valuation of 27 times its earnings despite weak operating income and declining sales forecasts projected through 2027. Recent improvements in retail and inventory have not translated into sustainable ear...

Analyst Insights
Bearish
4 hours ago
$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

$5.57B stolen from Binance-linked wallets in possible record crypto hack; investigation ongoing.

At least $5.57 billion in cryptocurrency was moved out of Binance-linked wallets across Ethereum, Bitcoin, and Tron blockchains in what appears to be a major security breach. Binance has not confirmed a hack but is actively investigating the potentia...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App